Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-05-07

Clinical Trial Update: Effect of Pantoprazole on the Symptoms of Acid Reflux Disease in Adult Patients (BY1023/M3-341) [Phase 3]

View source ↗

Summary

Phase 3 trial BY1023/M3-341 evaluated pantoprazole for treating symptoms of acid reflux disease in adults; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pantoprazole (pantoprazole)

Snippet

Sponsor: Takeda | Conditions: Gastroesophageal Reflux Disease (GERD) | Phase 3 | Status: COMPLETED